Efficacy and safety of irinotecan monotherapy as third-line treatment for advanced gastric cancer
Crossref DOI link: https://doi.org/10.1007/s00280-016-3138-z
Published Online: 2016-08-26
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kawakami, Takeshi
Machida, Nozomu
Yasui, Hirofumi
Kawahira, Masahiro
Kawai, Sadayuki
Kito, Yosuke
Yoshida, Yukio
Hamauchi, Satoshi
Tsushima, Takahiro
Todaka, Akiko
Yokota, Tomoya
Yamazaki, Kentaro
Fukutomi, Akira
Onozawa, Yusuke
License valid from 2016-08-26